ANALYSIS OF TUMOR RELAPSE PROBABILITY AND OVERALL SURVIVAL PREDICTION FOLLOWING CONCOMITANT RADIOTHERAPY WITH TEMOZOLOMIDE USING FET PET IN PATIENTS WITH GLIOBLASTOMA

被引：0
|
作者：
Stetter, I [1 ,2 ]
Werner, J. [1 ,2 ]
Wollring, M. [1 ,2 ]
Ceccon, G. [2 ]
Lohmann, P. [3 ,4 ]
Stoffels, G. [3 ]
Mottaghy, F. M. [4 ]
Fink, G. R. [1 ,2 ,3 ]
Langen, K. [3 ,4 ]
Galldiks, N. [1 ,2 ]
机构：
[1] Univ Hosp Cologne, Fac Med, Dept Neurol, Cologne, Germany
[2] Univ Hosp Cologne, Cologne, Germany
[3] Res Ctr Juelich, INM 4, Inst Neurosci & Med INM 3, Julich, Germany
[4] RWTH Univ Hosp Aachen, Dept Nucl Med, Aachen, Germany
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae144.318
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prediction of recurrence and survival analysis after radiotherapy of glioblastoma using 11C-Methionine PET/CT and MR
    Vigil, Carmen
    Prieto, Elena
    Ribelles, Maria
    Olarte, Alicia
    Hernandez, Miguel
    Valtuena, German
    Quincoces, Gemma
    Richter, Jose
    Aristu, Javier
    Arbizu, Javier
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [32] Radiotherapy Planning of Glioblastoma using 11C-Methionine-PET/CT and MRI: Prediction of Recurrence and Survival Analysis
    Vigil, C.
    Prieto, E.
    Hernandez, M.
    Caicedo, C.
    Rodriguez-Ruiz, M.
    Garcia-Granero, M.
    Quincoces, G.
    Penuelas, I.
    Aristu, J.
    Arbizu, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S238 - S239
  • [33] Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme: Analysis of Long Survival Patients
    Mizumoto, M.
    Tsuboi, K.
    Okumura, T.
    Hashimoto, T.
    Oshiro, Y.
    Fukumitsu, N.
    Hayashi, Y.
    Ohkawa, A.
    Sakae, T.
    Sakurai, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S278 - S278
  • [34] PREDICTION OF RESPONSE TO LOMUSTINE-BASED CHEMOTHERAPY IN GLIOMA PATIENTS AT RELAPSE USING MRI AND FET PET
    Wollring, M. M.
    Werner, J.
    Bauer, E. K.
    Tscherpel, C.
    Lohmann, P.
    Kabbasch, C.
    Goldbrunner, R.
    Fink, G. R.
    Langen, K. J.
    Galldiks, N.
    NEURO-ONCOLOGY, 2022, 24
  • [35] Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis
    Erpolat, Ozge Petek
    Akmansu, Muge
    Goksel, Fatih
    Bora, Huseyin
    Yaman, Emel
    Buyukberber, Suleyman
    TUMORI JOURNAL, 2009, 95 (02): : 191 - 197
  • [36] Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy
    Noel, Georges
    Huchet, Aymeri
    Feuvret, Loic
    Maire, Jean Philippe
    Verrelle, Pierre
    Le Rhun, Emilie
    Aumont, Maud
    Thillays, Francois
    Sunyach, Marie Pierre
    Henzen, Chantal
    Missohou, Fernand
    de Crevoisier, Renaud
    Bondiau, Pierre Yves
    Collin, Philippe
    Durando, Xavier
    Truc, Gilles
    Kerr, Christine
    Bernier, Valerie
    Clavier, Jean-Baptiste
    Atlani, David
    D'Hombres, Anne
    Vinchon-Petit, Sandrine
    Lagrange, Jean Leon
    Taillandier, Luc
    JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (01) : 167 - 175
  • [37] Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy
    Georges Noel
    Aymeri Huchet
    Loic Feuvret
    Jean Philippe Maire
    Pierre Verrelle
    Emilie Le Rhun
    Maud Aumont
    François Thillays
    Marie Pierre Sunyach
    Chantal Henzen
    Fernand Missohou
    Renaud de Crevoisier
    Pierre Yves Bondiau
    Philippe Collin
    Xavier Durando
    Gilles Truc
    Christine Kerr
    Valérie Bernier
    Jean-Baptiste Clavier
    David Atlani
    Anne D’Hombres
    Sandrine Vinchon-Petit
    Jean Léon Lagrange
    Luc Taillandier
    Journal of Neuro-Oncology, 2012, 109 : 167 - 175
  • [38] Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide
    Berger, Kerstin
    Turowski, Bernd
    Felsberg, Joerg
    Malzkorn, Bastian
    Reifenberger, Guido
    Steiger, Hans-Jakob
    Budach, Wilfried
    Haussmann, Jan
    Knipps, Johannes
    Rapp, Marion
    Haenggi, Daniel
    Sabel, Michael
    Mijderwijk, Hendrik-Jan
    Kamp, Marcel A.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (01) : 253 - 262
  • [39] Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide
    Kerstin Berger
    Bernd Turowski
    Jörg Felsberg
    Bastian Malzkorn
    Guido Reifenberger
    Hans-Jakob Steiger
    Wilfried Budach
    Jan Haussmann
    Johannes Knipps
    Marion Rapp
    Daniel Hänggi
    Michael Sabel
    Hendrik-Jan Mijderwijk
    Marcel A. Kamp
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 253 - 262
  • [40] Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery
    Stummer, Walter
    Meinel, Thomas
    Ewelt, Christian
    Martus, Peter
    Jakobs, Olga
    Felsberg, Jorg
    Reifenberger, Guido
    JOURNAL OF NEURO-ONCOLOGY, 2012, 108 (01) : 89 - 97
12345